AR043019A1 - ORAL TRANSMUCOSIDE SOLID DOSAGE FORMS FREE OF SUGAR AND ITS USES - Google Patents
ORAL TRANSMUCOSIDE SOLID DOSAGE FORMS FREE OF SUGAR AND ITS USESInfo
- Publication number
- AR043019A1 AR043019A1 ARP040100337A AR043019A1 AR 043019 A1 AR043019 A1 AR 043019A1 AR P040100337 A ARP040100337 A AR P040100337A AR 043019 A1 AR043019 A1 AR 043019A1
- Authority
- AR
- Argentina
- Prior art keywords
- dosage forms
- solid dosage
- sugar
- oral
- transmucoside
- Prior art date
Links
Abstract
Formas de dosificación sólida transmucosal oral. Las formas de dosificación sólida son libres de azúcar siendo adecuadas para pacientes diabéticos y comprenden un agente farmacéutico fentanilo, entre otros y un excipiente farmacéuticamente aceptable apropiado. Preferentemente, las formas de dosificación sólida son bioequivalentes a formas de dosificación sólida que contienen azúcar. La bioequivalencia es obtenida preferentemente incorporando un agente ionizante, más preferentemente con la forma de un sistema buffer, a las formas de dosificación sólida, en una cantidad suficiente para mantener una porción del agente farmacéutico en estado ionizado cuando dicha composición se disuelve en la saliva. Método para la administración transmucosa 1.Solid oral transmucosal dosage forms. The solid dosage forms are sugar free being suitable for diabetic patients and comprise a fentanyl pharmaceutical agent, among others and an appropriate pharmaceutically acceptable excipient. Preferably, the solid dosage forms are bioequivalent to solid dosage forms containing sugar. Bioequivalence is preferably obtained by incorporating an ionizing agent, more preferably in the form of a buffer system, into solid dosage forms, in an amount sufficient to maintain a portion of the pharmaceutical agent in an ionized state when said composition dissolves in the saliva. Method for transmucosal administration 1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44483203P | 2003-02-04 | 2003-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043019A1 true AR043019A1 (en) | 2005-07-13 |
Family
ID=36166931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040100337 AR043019A1 (en) | 2003-02-04 | 2004-02-04 | ORAL TRANSMUCOSIDE SOLID DOSAGE FORMS FREE OF SUGAR AND ITS USES |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1747722A (en) |
| AR (1) | AR043019A1 (en) |
| ZA (1) | ZA200506833B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5410964B2 (en) * | 2006-05-23 | 2014-02-05 | オラヘルス コーポレーション | Two-layered intraoral adhesive tablet containing adhesive acacia gum |
| CN100998594B (en) * | 2006-12-26 | 2011-05-04 | 重庆医药工业研究院有限责任公司 | Solid oral medicine composition containing amodiaquine |
| MY185299A (en) * | 2007-10-11 | 2021-04-30 | Philip Morris Products Sa | Smokeless tobacco product |
| CN102451162A (en) * | 2010-10-21 | 2012-05-16 | 重庆市力扬医药开发有限公司 | Olanzapine medicine absorbed through oral mucosa |
| EP3541393A4 (en) * | 2016-11-18 | 2020-06-17 | The University Of Western Australia | Taste masking product |
| CN111398480A (en) * | 2020-04-21 | 2020-07-10 | 郑州安图生物工程股份有限公司 | Kit for simultaneously detecting triazole antifungal drugs and glycopeptide antibiotics and detection method thereof |
| CN113952312A (en) * | 2021-10-24 | 2022-01-21 | 重庆市力扬医药开发有限公司 | Silodosin medicine absorbed through oral mucosa |
-
2004
- 2004-02-04 CN CN 200480003493 patent/CN1747722A/en active Pending
- 2004-02-04 AR ARP040100337 patent/AR043019A1/en unknown
-
2005
- 2005-08-25 ZA ZA200506833A patent/ZA200506833B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200506833B (en) | 2006-05-31 |
| CN1747722A (en) | 2006-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
| PT833618E (en) | PHARMACEUTICAL FORM SOLID FOR ORAL USE | |
| AR040722A1 (en) | FORMULATIONS AND DOSAGE FORMS FOR THE CONTROLLED ADMINISTRATION OF TOPIRAMATO | |
| ES2167061T3 (en) | DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS. | |
| AR039744A1 (en) | METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION | |
| ES2117015T3 (en) | COMPOSITIONS CONTAINING SUMATRIPTAN. | |
| AR033444A1 (en) | SOLID DOSAGE FORM FOR THE ORAL ADMINISTRATION OF AN ACTIVE NICOTINE COMPOUND, THROUGH THE MUCOSE AND USE OF AN ACTIVE NICOTINE COMPOUND TO PREPARE IT | |
| ES488168A0 (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL OR MEDICINAL TABLETS FOR ORAL ADMINISTRATION, WITH DELAYED DELIVERY OF ACTIVE ACTIVE, IN TABLETS IN WHICH THE QUANTITY OF RELEASE OF THE ACTIVE AGENT IS DEFAULT. | |
| EE200300033A (en) | Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them | |
| AR065970A2 (en) | A SOLID ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND GLIBENCLAMIDE AND USE OF SUCH COMPOSITION | |
| AR058175A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALINE | |
| UY27553A1 (en) | PHARMACEUTICAL FORMULATIONS OF 5,7,14-TRIAZATETRACICLO (10.3.1.02,11.04,9) -HEXADECA-2/11), 3,5,7,9-PENTAENO | |
| UY27532A1 (en) | DOSAGE FORM OF DUAL CONTROLLED RELEASE. | |
| UY25544A1 (en) | NEFAZODONE DOSAGE FORM | |
| AR013117A1 (en) | A SOLID PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET THAT INCLUDES A BENZOFURAN DERIVATIVE WITH ANTIARRHYTHMIC ACTIVITY ADAPTED FOR ORAL ADMINISTRATION | |
| CO5640120A2 (en) | FORMULATION AND METHODS FOR THE TROMBOCITEMIA TREATMENT | |
| ES2195638T3 (en) | PREPARATIONS OF PHARMACEUTICAL COMBINATIONS IN SOLID FORM OF DOSAGE CONTAINING CARDEVILOL AND HYDROCLOROTIAZIDA. | |
| EA200702102A1 (en) | PLATES CONTAINING STEROID HORMONES | |
| ECSP034826A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE | |
| AR046036A1 (en) | RISEDRONATE COMPOSITIONS AND METHODS FOR USE | |
| AR043019A1 (en) | ORAL TRANSMUCOSIDE SOLID DOSAGE FORMS FREE OF SUGAR AND ITS USES | |
| ATE262893T1 (en) | DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| AR048050A1 (en) | MASTICABLE, NON-COMPRESSED, METHODS OF ADMINISTRATION INDIVIDUALLY DOSED | |
| PE20030830A1 (en) | AMBROXOL FOR THE TREATMENT OF PAINFUL STATES IN THE ORAL CAVITY AND PHARYNGEAL | |
| AR022621A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DEOXIPEGANINE FOR THE TREATMENT OF NICOTINE DEPENDENCE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |